Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients

NCT05710367 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Fabry Disease

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Placebo

Sponsor

Albina Nowak, MD